Recognizing the Signs of Pediatric Growth Hormone Deficiency: How Early Recognition and Advocacy Helped One Family Find Answers

It wasn’t until one of Benke’s friends confided that her own daughter had recently been diagnosed with Pediatric Growth ...
Business Wire

FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...
AOL

We all need HGH, the hormone responsible for growth. What exactly does it do?

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...
WebMD

Treating Growth Hormone Deficiency With Sogroya

Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...
Monthly Prescribing Reference

Lonapegsomatropin Under Review for Adult Growth Hormone Deficiency

A Prescription Drug User Fee Act target date of July 27, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...
Nasdaq

NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA

SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Australian registration of SKYTROFA® (lonapegsomatropin) as a new ...
Morningstar

What Parents Should Know About Pediatric Growth Hormone Deficiency (PGHD)

MISSION, Kan., June 16, 2025 /PRNewswire/ -- (Family Features) Pediatric growth hormone deficiency (GHD) is a relatively rare condition, affecting an estimated 1 in 4,000-10,000 children. Despite its ...
Nasdaq

Ascendis Pharma's sBLA for TransCon hGH in Adult Growth Hormone Deficiency Accepted by FDA for Review

Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...
Monthly Prescribing Reference

Once-Weekly Ngenla Approved for Pediatric Growth Hormone Deficiency

Credit: Pfizer. Ngenla is expected to be available in August 2023. The Food and Drug Administration (FDA) has approved Ngenla ™ (somatrogon-ghla), a once-weekly, human growth hormone analog for the ...
PR Newswire

Growth Hormone Deficiency Market Poised to Reach US$ 7 Billion by 2034, Driven by Advances in Combination Therapies and Innovative Drug Delivery Systems: TMR

Increasing prevalence of growth hormone deficiency is driving demand for innovative therapies and personalized treatment approaches in the market. WILMINGTON, Del., July 18, 2024 /PRNewswire/ -- The ...
Seeking Alpha

FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

First of many planned label expansions supporting Vision 2030 goal to become the leading endocrinology rare disease company On track to initiate basket trial for ISS, SHOX deficiency, Turner syndrome, ...